Daewon Pharmaceutical Co., Ltd.
Clinical trials sponsored by Daewon Pharmaceutical Co., Ltd., explained in plain language.
-
New allergy drug aims to clear noses and help asthma sufferers breathe easier
Symptom relief Recruiting nowThis study tests two allergy medications, DW1807 and DW1807-R2, in 274 adults who have year-round nasal allergies and asthma. The goal is to see which one better reduces nasal symptoms like stuffiness and runny nose over 4 weeks. Participants must have had allergies for at least …
Phase: PHASE3 • Sponsor: Daewon Pharmaceutical Co., Ltd. • Aim: Symptom relief
Last updated Apr 29, 2026 15:02 UTC
-
New drug meets painkillers: safety check in healthy volunteers
Knowledge-focused Recruiting nowThis early-stage study tests how a new drug called DW4421 interacts with three common NSAID pain relievers in 150 healthy adults aged 19 to 50. The goal is to check safety and measure drug levels in the blood. No treatment benefit is expected; it's about gathering important safet…
Phase: PHASE1 • Sponsor: Daewon Pharmaceutical Co., Ltd. • Aim: Knowledge-focused
Last updated May 01, 2026 16:00 UTC